Brachial Plexus Injury After Prone Positioning (BPX)

February 14, 2024 updated by: Filippo Binda, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Brachial Plexus Injury After Prone Positioning in Intensive Care Unit: a Prospective Observational Study

The goal of this prospective observational study is to estimate the prevalence of brachial plexus injury after prone positioning in patients with ARDS and to evaluate the safety of swimmer position. The main questions it aims to answer are:

  • Could arm positioning during pronation play a role in the development of any nerve injury at the brachial plexus level?
  • Is swimmer position safe when adopted during prone positioning?

Participants will be studied at selective time points using EMG assessment.

Study Overview

Detailed Description

Prone positioning will be performed according to the current guidelines. Particularly, face and limbs will be placed according to the "swimmer position", ensuring the face position in the direction of ventilator and limbs (one arm above head and opposite arm at side) positioned as to prevent abnormal extension or flexion against the shoulders and elbows. Patients will lie on low air loss pressure mattresses, thus avoiding the utilization of any thoraco-pelvic supports, which are not recommended. Electromyography (EMG) will be performed to evaluate the occurrence of brachial plexus injury (BPI).

Study Type

Observational

Enrollment (Estimated)

54

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Milano, Italy, 20122
        • Recruiting
        • Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients admitted in the ICU with severe ARDS, also secondary to pulmonary involvement of COVID-19, receiving invasive mechanical ventilation and requiring prone positioning to treat hypoxemia, as decided by the medical team.

Description

Inclusion Criteria:

  • Age ≥ 18 years old
  • Admission to ICU for severe ARDS
  • Administration of sedation and neuromuscular blocking agents
  • Presence of endotracheal intubation and mechanical ventilation
  • Use of prone positioning to treat hypoxemia

Exclusion Criteria:

  • Extracorporeal membrane oxygenation
  • Prone positioning performed in other centers
  • Prone positioning contraindications
  • Neurodegenerative disorders
  • Previous known brachial plexus injury

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of patients with signs of brachial plexus injury (BPI)
Time Frame: EMG will be perform at the end of the every cycle of prone positioning (each cycle is 16 hours on average) and within 24 hours before ICU discharge

Signs of BPI are the presence of (almost one of four EMG results):

  • Somatosensory Evoked Potential N20 latency of radial nerve and ulnar nerve > 10% compared to baseline
  • Somatosensory Evoked Potential N20 amplitude of radial nerve and ulnar nerve < 50% compared to baseline
  • Sensory Action Potential amplitude of radial nerve, ulnar nerve and median nerve < 50% compared to baseline
  • Compound Motor Action Potential amplitude of ulnar and median nerve < 50% compared to normative data (assessed before ICU discharge)
EMG will be perform at the end of the every cycle of prone positioning (each cycle is 16 hours on average) and within 24 hours before ICU discharge

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Safety of swimmer position adopted
Time Frame: The safety of the swimmer position will be evaluated within 24 hours before ICU discharge

The safety is defined in terms of:

  • number of patients with adverse events during prone positioning
  • number of patients with pressure ulcers after prone positioning
  • number of patients with ocular damage after prone positioning
  • number of patients with auricle damage after prone positioning
The safety of the swimmer position will be evaluated within 24 hours before ICU discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 6, 2022

Primary Completion (Estimated)

December 1, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

December 29, 2022

First Submitted That Met QC Criteria

January 11, 2023

First Posted (Actual)

January 20, 2023

Study Record Updates

Last Update Posted (Estimated)

February 15, 2024

Last Update Submitted That Met QC Criteria

February 14, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 6057

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Brachial Plexus Injury

Clinical Trials on Electromyography

Subscribe